FriendBookmark.com New BlogU Posts (RichardG111) RSS Feed

CD Bioparticles Introduces Innovative Agonist-Based Adjuvants for Enhanced Vaccine Efficacy

CD Bioparticles launches new line of Agonist-Based Adjuvants to support researchers.CD Bioparticles, a leading manufacturer and supplier of numerous drug delivery products and services, is excited to announce the launch of its new line of Agonist-Based Adjuvants to support researchers in various fields, including vaccines and immunotherapeutics. These new adjuvants are designed to significantly accelerate vaccine research and development by enhancing immune responses and improving overall vaccine efficacy.Adjuvants are components that enhance the immunogenicity of a vaccine when used in conjunction with the vaccine antigen. There is a wide variety of adjuvants, ranging from synthetic small molecule compounds to complex natural extracts and particulate materials. Classical human vaccine adjuvants include aluminium adjuvant, MF59, AS01, AS03, AS04 and CpG ODN 1018, which are widely licensed for use in a variety of vaccines and are known to increase antibody titres and enhance cellular immune responses.Based on their mechanism of action, adjuvants can be classified as immunostimulants and delivery systems. Immunostimulants act by mechanisms such as targeting the Toll-like receptor (TLR), cyclic guanosine adenosine monophosphate synthase interferon gene stimulator (cGAS-STING) and C-type lectin receptor (CLR). Delivery systems work through mechanisms such as prolonged antigen bioavailability, targeted APC, lymph node transport and antigen cross-presentation. These mechanisms provide multiple options for vaccine development.Agonist-based adjuvants work by activating specific immune receptors, such as TLRs, RIG-I-like receptors (RLRs), and STING, which are crucial for triggering innate and adaptive immune responses. By targeting these pathways, CD Bioparticlesâ novel adjuvants help vaccines generate a more robust and long-lasting immune memory, ultimately improving protection against diseases. They are compatible with a variety of vaccine antigens, making them versatile tools for vaccine development.For example, the RC-529 (Catalog: CDAD24-118-T) is a lipid A mimetic (aminoalkyl glucosaminide 4-phosphate) and an adjuvant with similar efficacy to MPL. RC-529 stimulates the innate immune system by signalling through Toll-like receptor 4. Another is the Recombinant (P. fluorescens) purified tetani toxin C-terminal fragment (Catalog: CDAD24-135-T). In vitro, it is a potent mucosal adjuvant and carrier molecule that generates mucosal antibody responses and/or induces systemic T-cell tolerance to relevant antigens.CD Bioparticlesâ latest research has focused on optimizing the design and delivery of agonist-based adjuvants, resulting in improved potency and safety. These agonist-based adjuvants have demonstrated remarkable potential in preclinical studies, which may play a vital role in addressing some of the most pressing challenges in vaccine development, including the need for more effective vaccines against emerging infectious diseases.CD Bioparticles offers a large selection of research-grade adjuvant products for adjuvant formulation, screening, and optimization. The company is committed to advancing the field of vaccine development and improving global health. For more information about CD Bioparticles and and its agonist-based adjuvants, please visit .About CD BioparticlesCD Bioparticles is an established drug delivery company that provides customized solutions for developing and manufacturing novel biocompatible drug delivery systems. It specializes in various formulation and drug delivery technologies, from conventional liposomes and PEGylated liposomes to polymer microspheres and nanoparticles for drug delivery. The company also provides contract research services for drug delivery formulation, formulation feasibility study, process development and scale-up, as well as analytical and non-clinical research services.

CD Bioparticles Launches Endotoxin Free Gold Nanoparticles for Biomedical Research and Bioassay Development

CD Bioparticles announces its new Endotoxin Free Gold Nanoparticles for biomedical research and bioassay development.With years of experience in the pharmaceutical and life science sectors, CD Bioparticles announces the availability of its new Endotoxin Free Gold Nanoparticles for biomedical research and bioassay development. These nanoparticles offer exceptional biocompatibility and can meet the stringent requirements of researchers and developers working in a variety of fields, including drug delivery, imaging, sensing, medical diagnostics, and therapeutics.Endotoxin-free gold nanoparticles are specially engineered gold particles with extremely low levels of endotoxin, a toxic substance produced by certain types of bacteria, the presence of which can interfere with experimental results or damage cells or tissues. These nanoparticles are typically coated with citrate to minimize their interaction with biological systems and increase their biocompatibility. Endotoxin-free gold nanoparticles are widely used in biomedical research and bioassay development.Committed to providing innovative and high-performance biomaterials, CD Bioparticles offers endotoxin-free gold nanoparticles for research applications requiring minimal levels of contamination, such as cytotoxicity studies, immunological studies and sterility testing. The endotoxin content of all batches has been verified by Limulus amebocyte lysate (LAL) testing. These nanoparticles offer exceptional purity and minimal endotoxin contamination to ensure reliable and reproducible results and are suitable for applications such as drug delivery, imaging, and biosensing.Endotoxin-free gold nanoparticles from CD Bioparticles are available in a range of sizes from 5 nm to 400 nm. These particles exhibit strong light scattering and absorption in the visible and near-infrared regions, making them ideal for various applications. Their renewable nature, excellent thermal, mechanical, and chemical stability, and low toxicity ensure their versatility and safety. Moreover, the surface chemistry of these nanoparticles can be easily modified with biomolecules like antibodies, aptamers, or peptides, enabling precise targeting of specific cells, tissues, or biomolecules.CD Bioparticles offers a range of functional group/ligand endotoxin free gold nanoparticles to meet diverse research and diagnostic needs, including citric acid-stabilized endotoxin free gold nanoparticles and tannic acid-stabilized endotoxin free gold nanoparticles. For example, the DiagNanoâ Gold Nanoparticles, Endotoxin Free, 100 nm (Cat. No.BG-100-EF) are citric acid-stabilized gold nanoparticles, with a maximum absorbance of 572 nm, supplied in 0.1 mM phosphate-buffered saline. These nanoparticles boast a purity of over 99.0% and are free of extraneous reactants. With endotoxin levels below 0.5 EU/mL, they are ideal for cellular studies and exhibit exceptional protein binding efficiency. To ensure optimal sterility, the nanoparticles are packaged in dust-free containers, maintaining the highest level of cleanliness.CD Bioparticles is dedicated to supporting researchers and scientists with their material needs by providing innovative products and exceptional services. These biocompatible nanoparticles offer researchers a powerful tool for advancing their work in a variety of fields. For more information about Endotoxin Free Gold Nanoparticles and other products, please visit .About CD BioparticlesCD Bioparticles is a leading manufacturer and supplier of various nanoparticles, microparticles, and coatings for R&D as well as commercialization across different application areas, including in vitro diagnostics, biochemistry, cellular analysis, cell separation, and immunoassay. The company also offers various custom services, including chemical surface-functionalization, fluorescent modification, antibody immobilization, as well as nucleic acid and oligo conjugation to meet client specifications.

CD Bioparticles Launches Innovative Organoid Construct Kit to Advance Drug Discovery

CD Bioparticles launches Organoid Construct Kits to the scientific community to facilitate the construction of complex organoid models.CD Bioparticles, a leading manufacturer and supplier of numerous drug delivery products and services, has announced the launch of its Organoid Construct Kits to the scientific community to facilitate the construction of complex organoid models, enabling res...

CD Bioparticles Introduces Innovative Stable-Isotope Labeled Particles

CD Bioparticles launches new line of Stable-Isotope Labeled Particles to the scientific community.With years of experience in the pharmaceutical and life science sectors, CD Bioparticles is excited to announce the launch of its new line of Stable-Isotope Labeled Particles to the scientific community, providing scientists and researchers with a powerful tool for a wide range of applications...

CD Bioparticles Announces Advanced Capabilities in Customized Liposomes for Targeted Delivery

CD Bioparticles announces its expanded capabilities in Customized Liposomes.CD Bioparticles, a leading manufacturer and supplier of numerous drug delivery products and services, is proud to announce its expanded capabilities in Customized Liposomes. This advancement allows researchers and developers to leverage the power of liposome technology for a wider range of applications.Liposomes ar...

CD Bioparticles Simplifies Multi-Analyte Detection with Advanced Multiplex Particles

CD Bioparticles announces its advanced line of multiplex fluorescence particles.With years of experience in the pharmaceutical and life science sectors, CD Bioparticles announces its advanced line of multiplex fluorescence particles designed to streamline complex biological assays in flow cytometry experiments. These particles exhibit low signal widths in the forward scatter, side scatter ...

CD Bioparticles Announces Offering of Polystyrene Family Polymers for Drug Delivery

CD Bioparticles announces the availability of Polystyrene Family polymers for a variety of drug delivery applications.[/SIZE][/FONT]CD Bioparticles, a leading manufacturer and supplier of numerous drug delivery products and services, is pleased to announce the availability of Polystyrene Family polymers for a variety of drug delivery applications. These polymers offer tunable physicochemical properties that enable sustained release profiles and improved drug bioavailability.[/SIZE][/FONT]The polystyrene family, a group of polymers derived from the styrene monomer, has attracted considerable interest in the field of drug delivery due to its versatility of properties and applications. Polystyrene consists of both homopolymers and copolymers that offer a wide range of options for customizing drug delivery systems to meet specific therapeutic needs.[/SIZE][/FONT]CD Bioparticles is committed to providing researchers with the tools they need to develop new and effective drug delivery systems. Recognizing the immense potential of the polystyrene family, CD Bioparticles is expanding its low PDI polymer portfolio to offer a variety of polystyrene family polymers with different molecular weights and surface properties to meet the specific needs of each drug delivery application.[/SIZE][/FONT]The companyâs polystyrene family polymers are a versatile platform for the design of drug carriers, offering several advantages. For example, the versatility of polystyrene is demonstrated by its ability to be modified for controlled drug release, bioadhesion and targeted drug delivery. The inert nature of polystyrene enhances drug stability and ensures the integrity of the drug formulation. In addition, polystyreneâs compatibility with a wide range of drugs and other materials allows the creation of versatile drug delivery platforms.[/SIZE][/FONT]Furthermore, the polystyrene familyâs compatibility with various manufacturing technologies, including micro- and nanoscale technologies, makes it versatile for drug carrier design. The tunable physicochemical properties of polystyrene contribute to its great potential for sustained release and improved drug bioavailability.[/SIZE][/FONT]In the evolving field of drug delivery, the polystyrene family offers a promising avenue for researchers and pharmaceutical developers, providing a platform to address the challenges associated with traditional drug formulations and paving the way for innovative therapeutic solutions. CD Bioparticles is dedicated to developing innovative products and services that help researchers advance drug delivery. The addition of these new polymers further demonstrates CD Bioparticlesâ commitment to helping researchers develop new and effective therapeutic solutions.[/SIZE][/FONT]CD Bioparticles provides a range of Low PDI polymers to tackle different drug delivery hurdles. They can improve drug absorption by increasing water solubility, protect drugs from degradation, and target them to specific sites. Additionally, these polymers allow controlled drug release and even co-delivery of multiple drugs within a single carrier, ultimately leading to more effective treatments with fewer side effects and improved patient convenience.[/SIZE][/FONT]CD Bioparticles offers a wide variety of Polystyrene Family polymers to meet the needs of its customers. To learn more about new polymers and other products from CD Bioparticles, please visit .[/SIZE][/FONT]About CD Bioparticles[/FONT][/SIZE][/FONT]CD Bioparticles is an established drug delivery company that provides customized solutions for developing and manufacturing novel biocompatible drug delivery systems. It specializes in various formulation and drug delivery technologies, from conventional liposomes and PEGylated liposomes to polymer microspheres and nanoparticles for drug delivery. The company also provides contract research services for drug delivery formulation, formulation feasibility study, process development and scale-up, as well as analytical and non-clinical research services.[/SIZE][/FONT]

CD Bioparticles Announces New Line of Conjugated Agarose Particles for Affinity Separation and Purification

CD Bioparticles announces the launch of its new line of Conjugated Agarose Particles for researchers.[/SIZE][/FONT]With years of experience in the pharmaceutical and life science sectors, CD Bioparticles is excited to announce the launch of its new line of Conjugated Agarose Particles with various particle sizes (45-500 Âm), designed to streamline protein purification workflows for researchers. These versatile particles offer a powerful solution for affinity separation and purification of proteins and antibodies.[/SIZE][/FONT]Agarose particles are porous gel microspheres that, depending on their size, can filter or separate mixtures of molecules. They are easily activated and can therefore bind to biomolecules in a reversible or irreversible manner. CD Bioparticles currently offers a wide range of agarose particles for the isolation and purification of proteins and antibodies, including basic agarose particles, functional agarose particles and conjugated agarose particles for scientific research.[/SIZE][/FONT]These newly launched conjugated agarose particles are available in various agarose ratios and particle sizes (ranging from 45 Âm to 500 Âm) to meet different requirements for flow rate, volume, elution conditions, and alkali resistance. In addition, these beads minimize nonspecific binding, resulting in high purity of isolated proteins. Furthermore, they offer high recovery during elution, meaning minimal protein loss. This reusability, along with their role as key reagents in chromatin immunoprecipitation, immunoprecipitation, and pull-down assays for isolating specific proteins from complex mixtures, makes conjugated agarose particles a versatile and cost-effective solution for researchers.[/SIZE][/FONT]These particles can be used in a variety of applications, including antibody fragmentation, purification of tagged proteins and antibodies, and pull-down assays. For example, for antibody purification, CD Bioparticles offers a variety of agarose particles conjugated to native or recombinant Protein A, Protein G, Protein A/G, and Protein L. These particles exhibit excellent physical and chemical stability and allow purification of antibodies from ascites, serum, and culture medium. For instance, Alkali-resistant Protein A Agarose Particles possess excellent alkali stability for effective cleaning and sterilization.[/SIZE][/FONT]For biotinylated molecules, CD Bioparticles offers agarose particles conjugated with streptavidin, avidin, monomeric avidin, avidin-biotin binding protein, deglycosylated avidin, and streptavidin for purification or coupling of biotinylated proteins and antibodies for further applications such as traction and immunoprecipitation assays. The elution conditions of monomeric avidin, avidin-biotin conjugated protein and streptavidin-agarose particles are mild and friendly to biotinylated related proteins. The deglycosylated avidin-agarose particles are more neutral and have a lower rate of non-specific binding, allowing multiple reuse.[/SIZE][/FONT]Immobilized Enzyme Agarose Particles, Antibody Conjugated Agarose Particles, Glutathione Agarose Particles, and Lectin Conjugated Agarose Particles are also available for custom research. With their unique combination of performance, versatility, and cost-effectiveness, CD Bioparticlesâ conjugated agarose particles provide researchers with a robust and efficient platform for isolating their proteins of interest, ultimately accelerating their research progress.[/SIZE][/FONT]CD Bioparticles offers Conjugated Agarose Particles for researchers in protein purification and related fields. For more information, please visit .[/SIZE][/FONT]About CD Bioparticles[/FONT][/SIZE][/FONT]CD Bioparticles is a leading manufacturer and supplier of various nanoparticles, microparticles, and coatings for R&D as well as commercialization across different application areas, including in vitro diagnostics, biochemistry, cellular analysis, cell separation, and immunoassay. The company also offers various custom services, including chemical surface-functionalization, fluorescent modification, antibody immobilization, as well as nucleic acid and oligo conjugation to meet client specifications.[/SIZE][/FONT]

CD BIOPARTICLES ANNOUNCES NEW LINE OF POLYACRYLAMIDES FOR DRUG DELIVERY STUDIES

CD Bioparticles is proud to announce the launch of its Polyacrylamides.[/SIZE][/FONT]CD Bioparticles, a leading manufacturer and supplier of numerous drug delivery products and services, announced the launch of its expanded line of low-PDI polymers, Polyacrylamides[/FONT]. The new product line offers different functional groups (e.g., acid, amine, and methoxy) and a variety of molecular weights (1.5 KDa-6,000 KDa), making them ideal for a wide range of applications, particularly for drug delivery.[/SIZE][/FONT]Low dispersion index polymers are a class of low molecular weight polymeric compounds. Typically, the structures of such polymers are designed to reduce their dispersion in solution, thereby improving their stability and controllability. Such polymers have important applications in the field of drug delivery, mainly due to their ability to efficiently carry and release drug molecules, thus improving drug bioavailability and therapeutic efficacy.[/SIZE][/FONT]Low PDI polymers offer several key benefits in drug delivery. These polymers have precise and controllable properties, making it easier to tailor their structure during synthesis for specific application requirements. Additionally, they exhibit higher reaction efficiencies due to their narrower molecular weight distribution, resulting in uniform polymer structures. This uniformity contributes to stable drug carriers and controlled drug release. Moreover, low PDI polymers enable targeted drug delivery by allowing better control over carrier shape and surface properties, thereby concentrating drugs at the diseased site while minimizing impact on normal tissues. In summary, these polymers play a crucial role in advancing drug delivery systems by improving stability, precision, and therapeutic outcomes.[/SIZE][/FONT]Polyacrylamides are water-soluble synthetic linear polymers made from acrylamide or the combination of acrylamide and acrylic acid. With a commitment to excellence and sustainability, CD Bioparticles has expanded its portfolio of low PDI polymers to offer the research community a wide range of Polyacrylamides with functional groups (e.g., acid, amine, cyanide, and methoxy) and a variety of molecular weights (1.5 KDa-6,000 KDa). These new products can be used for various applications, including drug delivery, wound healing, and tissue engineering.[/SIZE][/FONT]CD Bioparticlesâ quality polyacrylamide products can help scientists address critical challenges in drug delivery, including the low water solubility of drugs, their susceptibility to environmental factors (e.g., light, oxygen and humidity), the need for targeted delivery, controlled release, and combination therapy. By encapsulating drugs within these polymers, CD Bioparticles enhances drug bioavailability, stability, and precision while facilitating joint administration of multiple drugs. CD Bioparticlesâ innovative solutions contribute to advancing drug delivery research and improving patient outcomes.[/SIZE][/FONT]CD Bioparticles is committed to advancing drug delivery research and leveraging the power of polyacrylamide to create innovative solutions that help its customers achieve their research goals. To learn more about new polyacrylamides and to explore other low-PDI polymers from CD Bioparticles, please visit .[/SIZE][/FONT]About CD Bioparticles[/FONT][/SIZE][/FONT]CD Bioparticles is an established drug delivery company that provides customized solutions for developing and manufacturing novel biocompatible drug delivery systems. It specializes in various formulation and drug delivery technologies, from conventional liposomes and PEGylated liposomes to polymer microspheres and nanoparticles for drug delivery. The company also provides contract research services for drug delivery formulation, formulation feasibility study, process development and scale-up, as well as analytical and non-clinical research services.[/SIZE][/FONT]

CD BIOPARTICLES INTRODUCES INNOVATIVE AGAROSE PARTICLES FOR PURIFICATION OF PROTEINS AND ANTIBODIES

CD Bioparticles proudly announces the launch of its Agarose Particles for isolation and purification of proteins and antibodies.[/SIZE][/FONT]With years of experience in the pharmaceutical and life science sectors, CD Bioparticles proudly announces the launch of its latest product line of Agarose Particles[/FONT] for isolation and purification of proteins and antibodies. These versatile microspheres, available in diameters ranging from 25 nm to 500 Âm, empower researchers with a powerful tool for a wide range of applications.[/SIZE][/FONT]Agarose particles are porous gel microspheres that, depending on their size, can filter or separate mixtures of molecules. These particles are easily activated to bind reversibly or irreversibly to biomolecules. They can be used for batch or column purification of proteins and antibodies and are well suited for biopharmaceutical applications. In addition, their large internal porosity allows the purification of larger biomolecules such as monoclonal antibodies. Meanwhile, their particle size distribution is mainly between 20 and 300 Îm. Small particle sizes are suitable for very high resolution polishing steps, while large particle sizes are suitable for capture steps. Furthermore, the volume required also influences the choice of particle size, as large volumes typically require larger particle sizes.[/SIZE][/FONT]Agarose particles are available in different percentages, e.g., 2%, 4% and 6%, allowing better separation of molecules according to their size. Particles with a higher percentage of agarose are suitable for separating small globular proteins due to their smaller pore size. Similarly, particles with a lower percentage of agarose are more suitable for separating larger globular proteins. In addition, preactivated agarose particles can be used to bind biomolecules. Particles with proteins and antibodies on the surface are used as affinity chromatography resins, ion exchange chromatography resins, size-exclusion chromatography resins, and hydrophobic interaction chromatography resins. Enzyme-immobilized agarose particles can be used for antibody fragmentation.[/SIZE][/FONT]CD Bioparticles offers a wide range of agarose particles, including Basic Agarose Particles, Functional Agarose Particles and Conjugated Agarose Particles. These precision-engineered agarose particles elevate research and separation processes in various applications, such as isolation and purification of proteins with affinity tags and antibodies, preparation of antibody fragments, and conjugation of proteins, antibodies and peptides. These particles can also be used in pull-down assays, chromatin immunoprecipitation assays and immunoprecipitation assays.[/SIZE][/FONT]For example, DiagAgâ Carboxyl Agarose Particles, 25 Îm (DAG-BE23-01) have good rigidity and monodispersity. Their surface is modified with abundant carboxyl groups (-COOH), which allows them to bind to biological ligands containing primary amine groups such as proteins, antibodies, oligonucleotides and drug molecules by covalent coupling methods. These new products are an important support tool for molecular biology and medical research.[/SIZE][/FONT]CD Bioparticles is committed to providing valuable tools to researchers in the biopharmaceutical and life science fields. For more information and to explore the full range of Agarose Particles, please visit CD Bioparticles at .[/SIZE][/FONT]About CD Bioparticles[/FONT][/SIZE][/FONT]CD Bioparticles is a leading manufacturer and supplier of various nanoparticles, microparticles, and coatings for R&D as well as commercialization across different application areas, including in vitro diagnostics, biochemistry, cellular analysis, cell separation, and immunoassay. The company also offers various custom services, including chemical surface-functionalization, fluorescent modification, antibody immobilization, as well as nucleic acid and oligo conjugation to meet client specifications.[/SIZE][/FONT]

The Mechanism of Adverse Immune Reactions of LNP-mRNA

Many clinical trials of mRNA-based drugs or vaccines have failed to successfully pass Phase I or Phase II. The reasons behind this are various, including low efficacy of candidate drugs and lower-than-expected clinical risk/treatment benefit profiles. Preclinical safety assessments aim to identify well-tolerated and efficacious LNP-mRNA formulations, and when toxicity is observed, in vivo, in vitro and ex vivo experiments aim to understand the underlying mechanisms and, ideally, improve the formulations design under development.The main safety issues of LNP-mRNA preparations in preclinical development can be divided into immunopathogenicity and liver and spleen toxicity (only studies on modified and/or dsRNA-purified mRNA are considered). Understand the different formulations of LNP-mRNA preparations and mechanisms of adverse effects help us better design and optimize drug candidates that are well tolerated and effective.Liver and Spleen ToxicitySince LNP-mRNA has significant liver and spleen biodistribution, microscopy and histopathology of the liver and spleen are standard practice during preclinical development. Acute drug-induced liver injury is routinely assessed by measuring plasma levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST), and alkaline phosphatase (APT). Most current published studies of LNP-mRNA therapeutic applications report only mild pathological findings.In one such study, modified mRNA encoding human methylmalonyl-CoA mutase (hMUT) was synthesized to treat methylmalonic acidemia/aciduria (MMA), a serious A hypomorphic mouse model of a rare metabolic disorder. At the highest intravenous dose of the LNP-mRNA formulation, there were no clinical chemistry findings, but 80% of mice had mild paracentral splenic artery lymphopenia. This effect, which was attributed to LNPs rather than hMUT mRNA or its expression, was also observed in LNPs carrying mRNA for green fluorescent protein (eGFP).In another study, modified mRNA encoding human arginase was used to treat a mouse model of arginase deficiency. Although there were no biochemical or histopathological findings, electron microscopy of liver sections from the group receiving luciferase mRNA single control preparation revealed the presence of submicron-sized lipid droplets.Furthermore, a single intramuscular injection of an LNP-mRNA preparation encoding the influenza hemagglutinin H3 antigen showed increased levels of AST, ALT, and C-reactive protein in a rabbit model. Histopathological findings of the liver included focal subscapular vacuoles, inflammatory cell and erythroid infiltrates, and pleocytosis (lymphocyte expansion) was observed in the germinal center of the spleen.Immune ResponseThe human bodyâs adverse immune responses to nanomedicines include reactogenicity, hypersensitivity reactions, systemic complement immune responses, and cytokine-mediated reactions after vaccination. For LNP-mRNA-based therapies in preclinical development, such events may compromise their safety and reduce therapeutic efficiency. However, due to the inherent compositional complexity of LNP vectors, it is not easy to determine which components of a given LNP-mRNA complex elicit unwanted innate immune responses and which conditions may exacerbate them (dose, route of administration, pre-existing inflammation, etc.) thing.TLR Activation and Cytokine SecretionStimulation of TLRs by LNP-mRNA is considered to be the upstream pathway of cytokine production. In a related study, lipopolysaccharide (LPS) was used to treat mice to induce inflammation. The inflamed mice then received a single intravenous injection of LNP-mRNA and exhibited IL-6, a C-C motif chemokine ligand 2 (CCL2) and other proinflammatory cytokines (in serum) and C-X-C motif chemokine ligand 2 (CXCL2, in liver) are elevated. Similar immune responses were observed when mice were given empty LNP. Research points out that the ionizable cationic lipid ALC-0315 is the most important immune-stimulating ingredient. The inflammatory phenotype is ablated in macrophage-depleted mice as well as Tlr4â/â mouse models. Interestingly, similar findings were observed with mRNA preparations using two other ionizable cationic lipids (DLin-MC3-DMA or C12-200).In an independent study, colocalization of TLR4 and LNP-mRNA in endosomes following in vitro LPS activation of mouse macrophages corroborates the hypothesis that LNP-mRNA preparations trigger innate immune system responses via TLR4 in response to pre-existing inflammation. Under these conditions, LNP endosomal escape using cKK-E12 ionizable cationic lipids is impaired, while phosphorylation of protein kinase R (PKR) downstream of TLR4 results in reduced translation of intracytoplasmic mRNA. Although LNP alone was not introduced for control, these TLR4-related findings point to lipid-mediated biological effects on delivery efficiency.Overall, TLR activation and pro-inflammatory cytokine release are common innate immune system effects induced by LNP-mRNA, sometimes causing strong adverse reactions and affecting protein translation. Activation of TLR4 by ionizable cationic lipids is a possible upstream initiating event, although the exact molecular mechanism has not yet been elucidated. Other factors may also be necessary to cause or exacerbate the inflammatory effects, which may depend on the payload, dose, or route of administration, etc.Inflammasome ActivationInflammasome activation was recently identified as a unique innate immune system effect induced by LNP-mRNA. The canonical pathway of pyroptosis requires an initiation signal to activate NF-ÎB and initiate the transcription of NOD-like receptor pyrin domain protein 3 (NLRP3) and pro-IL-1Î, the latter of which may originate from TLR activation. Secondary signals initiate the assembly and activation of the NLRP3 inflammasome.In an in vitro study, NLRP3 inflammasome activation resulted in reduced mRNA transfection efficiency after administration of DLin-MC3-DMA-based LNP-mRNA to bone marrow-derived macrophages in vitro. LPS serves to provide the initiation signal, but mRNA may also promote initiation through TLR activation. Lysosomal disruption and damage-associated molecular patterns serve as secondary signals during LNP-mRNA escape. NLRP3 activation can be inferred from IL-1Î release, cleaved gasdermin D and caspase 1 expression, and cathepsin B maturation.When human peripheral blood mononuclear cells (PBMC) are treated with LNP-eGFP mRNA configured with DLin-MC3-DMA or SM-102, IL-1Î and other pro-inflammatory cytokines such as IL-6, CCL2, CCL4 and TNF, etc.) release increases dramatically. Notably, the SM-102-based empty formulation also triggered strong IL-1Î secretion, suggesting that these lipids provide priming and activation signals for inflammasome activation.Complement Activation and Hypersensitivity ReactionsComplement proteins in plasma and cell surfaces are essential components of the innate immune system. Complement activation, a series of proteolytic events, supports the phagocytic clearance of pathogenic substances or particles. The emergence of biologics and nucleic acid therapies has rapidly elevated immunotoxicological studies related to complement activation into routine practice in drug development. Identification of pathogenicity is the upstream pathway that initiates complement activation, of which there are three pathways: the classical pathway, initiated by pattern recognition of IgG or IgM; the alternative pathway, initiated by the hydrolysis of the thioester bond in complement protein C3.LNP-mRNA preparations have been shown to activate the complement pathway. In an in vivo study in a cynomolgus monkey model, intravenous administration of LNP-mRNA expressing hEPO resulted in a mild and reversible increase in plasma complement protein C3a and C5b-9 levels. In another study, C3b/c and soluble C5b-9 were also increased after incubation of CD40L-expressing LNP-mRNA in complement-active human serum. Anti-PEG IgM is required for complement activation and is associated with loss of LNP integrity. These findings are consistent with previous reports that immune cells mediate accelerated clearance of nanomedicine formulations due to immunoglobulin opsonization and complement activation.

Microfluidics Revolution: Polystyrene Particles Powering Miniaturized and Automated

Traditional immunoassays based on the format of 96-well microtiter plates are widely used in analytical laboratories and have become increasingly automated with the introduction of robotics technology in recent years, thereby enhancing assay throughput. Most clinical analyzers essentially operate as âstand-alone laboratories,â featuring precise, accurate, and highly reproducible progra...

PLGA Nano Drug Carrier

Poly(lactic-co-glycolic acid) (PLGA) is a functional polymer organic compound randomly polymerized by lactic acid (PLA) and glycolic acid (PGA). It has been approved by the U.S. Food and Drug Administration It is certified by the Food and Drug Administration (FDA) and is a copolymer material available on the market. PLGA has good biocompatibility, biodegradability, mechanical strength, goo...

Colored Polystyrene Particles in Developing Rapid and Affordable Point-of-Care Diagnostics

What is POCT?POCT (Point-of-Care Testing) refers to clinical and bedside testing conducted in close proximity to patients. It is often not performed by clinical laboratory personnel. POCT holds significant importance in disease prevention, etiology determination, prognosis, enhancing treatment outcomes, and reducing healthcare expenses. It meets clinical testing needs across various health...

Exploring Dyed Polystyrene Latex Particles Enhancing Immunoassays and Beyond

What are Dyed Polystyrene Latex Particles?[/FONT][/FONT]Polystyrene particles[/FONT] (PSP) are commercially available in different sizes, ranging from 15 nanometers to several micrometers, with narrow size distributions and various surface chemistries. Additionally, polystyrene is generally considered inert and nontoxic, making it safe for use in a variety of biological assays. [/FONT]Dyed polystyrene latex particles[/FONT] or colored latex beads have excellent multiplexing capability and have the following characteristics: a. Diversity, that is, diversity of particle size, color, and color depth; b. High labeling efficiency; c. Stability, it has good chemical and physical properties in aqueous solution. These characteristics provide a strong guarantee for the rapid development and application of colored latex particles in medical diagnostic technology.[/FONT][/FONT]Shop for Colored Polystyrene Particles[/FONT][/FONT]Black Polystyrene Particles[/FONT][/FONT]Red Polystyrene Particles[/FONT][/FONT]Blue Polystyrene Particles[/FONT][/FONT]Violet Polystyrene Particles[/FONT][/FONT]Green Polystyrene Particles[/FONT][/FONT]Yellow Polystyrene Particles[/FONT][/FONT]Orange Polystyrene Particles[/FONT][/FONT] [/FONT][/FONT]At present, there are three main methods for preparing colored latex particles: the first is to copolymerize dye monomers and latex monomers; the second is to prepare latex particles first, then modify them with active groups on the surface of the particles, and finally combine the dye molecules by covalent cross-linking to the particle surface; a third method is to prepare colored latex particles by physically trapping or absorbing dye molecules.[/FONT][/FONT]Immunochromatographic Assay: Leveraging Colored Polystyrene Particles[/FONT][/FONT](Adapted from Wang, J, 2021)[/FONT][/FONT]Immunochromatographic assay (ICA), also known as lateral flow assay (LFA), is a rapid analysis technology with simplicity, speed, and sensitivity advantages. ICA is one of the most successful and widely used point-of-care tests (POCT) and has been successfully used for human chorionic gonadotropin (hCG) detection, serodiagnostic assays, cancer detection, cardiac markers and infectious microorganism detection. ICA has been widely used in many fields such as medicine and food safety. To enhance the sensitivity of colorimetric ICA, labeled nanomaterials need to exhibit deep and bright color signals. Utilizing new colored nanomaterials as labeled probes is an important strategy to improve sensitivity. Wang et al. developed [/FONT]crimson red 0.2000 Âm polystyrene microspheres[/FONT] (PMs)-based ICA for sensitive and quantitative detection of AFB[/FONT]1[/SIZE][/FONT] in corn. PMs-ICA is more sensitive than CG (colloidal gold)-ICA, and results can be obtained with the naked eye rather than using a reader. Nagaoka et al developed a new visual immunodiagnostic method using [/FONT]red latex beads[/FONT] to detect urinary IgG4. Taking those with ICT antigen test positive as the standard (136/156), the sensitivity is 87.2%. Comparing gold nanoparticles with latex beads, it can be observed that lateral flow assays using latex beads on the conjugation pad have higher sensitivity and specificity than assays using gold nanoparticles.[/FONT][/FONT]Latex Agglutination Assays: The Role of Dyed Polystyrene Particles[/FONT][/FONT]Latex agglutination is the change in agglutination capacity observed when a sample containing a specific antigen is mixed with antibodies coated on the surface of latex particles. Agglutination can also be reversed by coating latex particles with specific antigens and testing the sample for the presence of specific antibodies. Latex agglutination assays have the advantage of rapid results, often determined within minutes, and this type of reaction does not require expensive equipment to evaluate the sample. A user-friendly latex agglutination assay was developed and evaluated for the serodiagnosis of human brucellosis. The assay was obtained by coating [/FONT]blue latex beads[/FONT] with Brucella lipopolysaccharide and drying the activated beads onto a white agglutination card. For initial serum samples collected from patients with culture-confirmed brucellosis, the assay had a sensitivity of 89.1% (95% CI, 76-96) and a specificity of 98.2% (95% CI, 96-99). Grace et al. developed a rapid diagnostic test for porcine JEV diagnosis and serosurveillance using [/FONT]violet-dyed polystyrene beads[/FONT] (0.80 Îm) that can be easily applied in the field and is useful to fill the gap between existing diagnostic methods and surveillance programs.[/FONT][/FONT]Advantages of Colored Polystyrene Particles in Immunoassays[/FONT][/FONT]Latex particles formed from amorphous polymer (usually polystyrene) represent a class of particles that have applications in many different aspects of biotechnology. These monodisperse particles range in size from 20 nm to 160 Âm, with [/FONT]100-400 nm[/FONT] covering the typical range used in lateral flow immunoassays. Colored polystyrene beads are inexpensive. Second, because they are doped with organic dyes, they are available in a variety of colors, with red, blue, black, and green being the most popular choices for lateral flow assays. The versatility of latex particles in color selection and compatibility with many biological matrices make them ideal candidates for labeling in many lateral flow immunoassays.[/FONT][/FONT]References[/FONT][/FONT]1. [/SIZE][/FONT]Nagaoka, F., Itoh, M., Samad, M. S., Takagi, H., Weerasooriya, M. V., Yahathugoda, T. C., â & Kimura, E. (2013). Visual detection of filaria-specific IgG4 in urine using red-colored high density latex beads. Parasitology international, 62(1), 32-35.[/FONT][/FONT]2. [/SIZE][/FONT]Wang, J., Li, X., Shen, X., Zhang, A., Liu, J., & Lei, H. (2021). Polystyrene microsphere-based immunochromatographic assay for detection of aflatoxin B1 in maize. Biosensors, 11(6), 200.[/FONT][/FONT]3. [/SIZE][/FONT]Abdoel, T. H., & Smits, H. L. (2007). Rapid latex agglutination test for the serodiagnosis of human brucellosis. Diagnostic microbiology and infectious disease, 57(2), 123-128.[/FONT][/FONT]4. [/SIZE][/FONT]Grace, M. R., Dhanze, H., Pantwane, P., Sivakumar, M., Gulati, B. R., & Kumar, A. (2019). Latex agglutination test for rapid on-site serodiagnosis of Japanese encephalitis in pigs using recombinant NS1 antigen. Journal of Vector Borne Diseases, 56(2), 105-110.[/FONT][/FONT]

Research on the Application of Nanoformulation in Transdermal Drug Delivery System

As a promising systemic drug delivery method, transdermal drug delivery system (TDDS) is easier and more convenient to operate than traditional oral, intravenous and subcutaneous injection methods. It can improve patient compliance while also avoiding First-pass effect and drug side effects. As the largest organ of the human body, the skin is also the bodyÃââs first line of defense ag...

Zeta Potential: A Fundamental Measure for Colloidal Behavior

What is Zeta Potential?Zeta potential (ZP) is a physical property exhibited by any particle in a suspension, macromolecule or material surface. ZP is an analytical technique used to determine the surface charge of nanoparticles in colloidal solutions. The surface of a charged particle attracts and binds firmly to a thin layer of opposite charge, forming a thin layer of liquid called the St...

Application of Carrageenan Hydrogel in Biomedical Field

Hydrogel is a three-dimensional network of hydrophilic polymers that swells in water without dissolving. Because the polymer contains a large number of hydrophilic groups, the hydrogel can absorb and lock a large amount of water. After absorbing water, the hydrogel network can maintain its original shape without being destroyed. Hydrogels are widely used in tissue engineering, drug deliver...

Illuminating the World of Plasmonic Nanoparticles: Unveiling the Mystery of Plasmons

Surface plasmon resonance (SPR) and surface-enhanced Raman scattering (SERS) are two key surface plasmon technologies that ultimately enable single-molecule-level chemical and biological sensors. Due to the tremendous progress in solution-based synthesis methods, plasmonic nanoparticles with various complex shapes (e.g., spheres, rods, and prisms) have been widely used for surface plasmon ...

Micelle vs Liposome

Micelles refer to molecularly ordered aggregates that begin to form in large quantities after the surfactant concentration reaches a certain value in an aqueous solution. In micelles, the hydrophobic groups of surfactant molecules aggregate to form the core of the micelle, and the hydrophilic polar groups form the outer layer of the micelle. Liposomes are an artificial membrane. In the wat...

Gold Nanoparticles in Medicine: A Tiny Marvel with Big Potential

With the continuous development of nanotechnology, gold nanoparticles are widely used in the field of medicine. Gold nanoparticles not only have good controllability, biocompatibility, and biosorption, but also have a high degree of stability, and can achieve specific biometrics and functions through surface modification. Therefore, it has become an important nanomaterial in biomedicine.Th...

Application of 3D Printing Bioinks Tissue Repair and Regenerative Medicine

Introduction to 3D PrintingIn the 1980s, American engineer Charles Hull developed rapid prototyping technology by combining points and surfaces and then using light reinforcement. After numerous failures, he finally invented stereolithography technology. Based on this technology, the worldÃââs The first 3D printer came into being. By the end of the 1990s, researchers combined 3D print...

Mastering Colloidal Gold Handling, Storage, and Applications

Colloidal gold is a certain-size gold particle synthesized by gold ion reduction and polymerization of chloroauric acid (HAuCl4) under the action of reducing agents such as white phosphorus, ascorbic acid, sodium citrate, tannic acid, and so on. Due to electrostatic action, gold particles repel each other and suspend into a stable colloidal state, forming a negatively charged hydrophobic c...

Introduction to Drug Delivery System Based on Apoptotic Body

Extracellular vesicles are a series of membrane-structured vesicles released by cells, including exosomes, microvesicles, and apoptotic bodies. Extracellular vesicles are composed of various lipids and membrane proteins, some of which special membrane proteins help target specific tissues and cells, while others ensure that non-specific interactions are minimized, these physiological prope...

How to Calculate the Volume, Mass, and Concentration of Gold Nanoparticle

Gold is a chemically stable metal with a molar mass of 196.96657 g/m and a density of 19.3 g/cm3. It is often used for decoration and money, but its properties change strangely when its size shrinks to the nanometer level. Gold nanoparticles have special physical and chemical properties different from bulk gold because of their small size effect, surface effect, quantum size effect, and macroscopic quantum tunneling effect.Gold nanoparticles have the characteristics of high electron density, high dielectric properties, and high catalytic efficiency, and can combine with a variety of biological macromolecules without affecting their biological activity. Therefore, it has been widely used in disease diagnosis and treatment, as well as drug delivery and other aspects. The volume, mass, and concentration of gold nanoparticles are the basic characteristics of gold nanoparticles. We will describe how to calculate these parameters of spherical gold nanoparticles and gold nanorods.Calculation of the volume of gold nanoparticlesThe gold nanoparticleÃââs volume is determined by measuring its dimensions. The particleÃââs dimensions are measured using a transmission electron microscope (TEM) to calculate volume, for instance.The volume of spherical particles is V=4/3ÃÅâr3, where r represents the sphereÃââs radius.The volume of rod-shaped particles, on the other hand, is V=ÃÅâr2l, where r represents the rodÃââs radius and l the length.Calculation of the mass of gold nanoparticlesOnce the volume of nanoparticles is calculated, their mass can be determined by multiplying the volume by the density of the material (Ã), according to the formula m=VÃ. Typically, the density of nanomaterials is the same as the bulk density, however, for some materials like silica, the atomic structure differs from the bulk density. In these cases, a corrected density should be used. The nanoparticle density and bulk density of gold materials are presented in the following figure.The nanoparticle density and bulk density of gold materialsCalculation of the concentration of gold nanoparticlesTo determine the concentration of gold nanoparticles, the first step is to calculate the total mass of gold in nanoparticle form within the solution. An estimate can be obtained by assuming that all reagents initially added are converted to gold nanoparticles, with no accounting for low reaction yield or processing loss. This assumption entails that all the added gold chloride is reduced to elemental gold. The direct measurement method for determining element concentration yields more precise results.For instance, the concentration of gold in the purified gold nanoparticle solution is directly measured via ICP-MS. This measurement permits calculation of the nanoparticle number concentration by dividing the solutionÃââs total mass by that of an individual nanoparticle Ãââ the formula being N=MC/m.Where MC represents the mass concentration of elements and m is the mass of each individual nanoparticle. If the total mass concentration is measured in g/mL and the particle mass is presented in g/nps, the concentration can be calculated as nps/mL.Molar concentration of gold nanoparticlesIn chemical and biological studies, molar concentration is typically used to express concentration and refers to the number of moles per liter of the substance. It is important to note that the molar concentration of particles differs from that of the elements that compose the nanoparticles. To calculate the molar concentration of particles, the formula M=N/NA is utilized, where N represents the number concentration of nanoparticles (in nps/L), and the denominator is the Avogadro constant (NA=6.02Ãâ1023).The molar concentration of gold nanoparticles is generally in the range of nM to pM. For example, our DiagNanoÃâÂ Gold Nanoparticle, 20 nm has a total elemental gold concentration of 0.0483 mg/mL, a corresponding particle number concentration of 6.82Ãâ1011 nps/mL, and a particle molarity of 1.14 nM.CD Bioparticles provides online conversion tools to help customers convert parameters such as the volume, mass, and concentration of gold nanoparticles.

Natural Nanocarriers for Delivery Protein Drug

Protein accounts for 18-20% of the total mass of the human body and is the main carrier of human life activity. Protein has a range of complex functions in the organism, and many human diseases are closely related to the functional regulation of protein. For example, ParkinsonÃââs disease (PD). It is understood that protein-stable imbalance disorders associated with mitochondria are i...

Enhancing Immunoassays with Carboxylated Magnetic Beads: A Breakthrough in Diagnostics

What is A Carboxyl Magnetic Bead?Carboxyl magnetic beads are a kind of biological magnetic beads, which generally have the characteristics of superparamagnetism, fast magnetic response, large specific surface area, monodisperse, colloid stability, and so on. The surface modification of carboxyl magnetic beads is rich in carboxyl groups, which can bind proteins, nucleic acids, and peptides ...

What is a Nano-Drug Delivery System of Natural Polysaccharides

Nano drug delivery system refers to the drug delivery system composed of natural or synthetic polymer materials with a particle size of 1-1000 nm. Nano-drug delivery carriers have the characteristics of biodegradability, low drug toxicity, slow-controlled release and targeted drug delivery, and are widely favored by researchers in the field of medicine. Metabolism, which can play a sustain...

What Are Melamine Resin Particles?

Melamine (1, 3, 5-triamino-2, 4, 6-triazine) resin, or melamine formaldehyde (MF) is one of the hardest and stiffest thermosetting polymers, which provides good properties and performance. It is an amino resin and has various material advantages, such as transparency, better hardness, thermal stability, excellent boil resistance, scratch resistance, abrasion resistance, flame retardant, mo...

How to Prepare Sodium Alginate Microspheres with Controllable Particle Size

Sodium alginate is a sodium salt of polyanionic alginic acid. It is a natural high molecular polysaccharide polymer extracted from natural brown algae. It has the advantages of wide source, low price, good biocompatibility, and degradability. Contains multiple hydroxyl and carboxyl functional groups, so it can react with a variety of divalent or trivalent cations to form hydrogels, and is ...